
“AI Agents Unlock Faster Global Market Access: Solving the Core Challenges of Clinical Evaluation and Global Registration”
This presentation will focus on Clinsota’s independently developed vertical multi-agent AI platform for medical device clinical compliance and explain how it canthrough multi-agent role specialization, task orchestration, and structured data,enablethe automated execution of complex compliance tasks, while leveraging multi-agent collaboration and automated reasoning to deliver intelligent end-to-end clinical evaluation workflows. It will further examine how, with regulations as the foundation, clinical evaluation and registration activities can achieve standardized and consistent outputs, turning what was oncean uncertain process heavily dependent on individual experience into a reproducible and traceable path.
With AI, medical device global expansion no longer relies on experience-driven improvisation, but on rule-based execution


